CTRI/2020/05/024982尚未招募未知
SAGE OF HYDROXYCHLOROQUINE AND AZITHROMYCIN IN INDICATED CONFIRMED COVID-19 POSITIVE CASES FOR ITS EFFICACY IN EARLY NEGATIVE CONVERSION- PILOT OBSERVATIONAL STUDY AIIMS RAIPUR.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •i)All age group (special: children, all preganant women);
- •ii)PCR documented SARS-CoV-2 carriage in nasopharyngeal sample at admission whatever their clinical status.
排除标准
- •Non consented.
- •Patients will be excluded if they have a known allergy to hydroxychloroquine /chloroquine and/ or Azithromycin and have any other contraindication to treatment with the study drug(Chloroquine or Azithromycin) including retinopathy, G6PD deficiency and QT prolongation.
- •Lactating mothers will be excluded based on their declaration.
研究者
相似试验
招募中
3 期
evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19COVID-19.COVID-19U07.1 COVIIRCT20200318046812N2Bagheiat-allah University of Medical Sciences906
尚未招募
3 期
Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19RespiratoryPACTR202005622389003Faculty of Medicine University Cheikh Anta Diop of Dakar Senegal.384
尚未招募
3 期
Efficay of two hydroxychloroquine based drug combination regimens in comparison to standard of care in The Treatment of Hospitalized COVID-19 PatientsCOVID 19PACTR202010519682638ational Institute for Pharmaceutical Research and Development NIPRD210
尚未招募
2 期
A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illnessCTRI/2020/04/024948ady Hardinge Medical College
进行中（未招募）
1 期
Azithromycin added to Hydrochloroquine in Patients Admitted to Intensive Care due to Coronavirus Disease 2019 (COVID-19) - Randomised Controlled Trial, phase IIIEUCTR2020-001456-18-CZadacní fond Donatio intensivistam240